Back to Search
Start Over
Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia.
- Source :
-
Blood [Blood] 2022 Mar 17; Vol. 139 (11), pp. 1766-1770. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 1528-0020
- Volume :
- 139
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Blood
- Publication Type :
- Academic Journal
- Accession number :
- 35298594
- Full Text :
- https://doi.org/10.1182/blood.2021014401